Desjardins Global Asset Management Inc. Moderna, Inc. Transaction History
Desjardins Global Asset Management Inc.
- $922 Million
- Q4 2023
A detailed history of Desjardins Global Asset Management Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Desjardins Global Asset Management Inc. holds 1,520 shares of MRNA stock, worth $46,010. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,520
Previous 1,498
1.47%
Holding current value
$46,010
Previous $154,000
1.95%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding MRNA
# of Institutions
925Shares Held
256MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.22 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.18 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$774 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$532 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$221 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $11.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...